Epinephrine Bitartrate, Lidocaine Hydrochloride Injection shortage (US): status and presentations
Shortage United States · first listed 22 February 2012 · updated 15 October 2026
| Dosage form | Injection |
|---|---|
| Therapy area | Anesthesia, Pediatric |
| Presentations | 8 unavailable, 5 limited, 9 available |
| Source | US FDA Drug Shortage Database (openFDA), checked 19 October 2026 |
Presentations affected
- Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) — Unavailable
- Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) — Unavailable
- Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) — Unavailable
- Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) — Unavailable
- Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) — Unavailable
- Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL — Unavailable
- Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL — Unavailable
- Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL — Unavailable
- Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) — Limited Availability
- Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) — Limited Availability
- Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) — Limited Availability
- Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) — Limited Availability
- Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) — Limited Availability
- Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL — Available
- Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL — Available
- Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL — Available
Strengths and packs as listed by the regulator. Manufacturer names and product codes are not shown.
What buyers can do
- Check whether other registered presentations or strengths can be used, and ask your wholesaler about allocation.
- For hospital and tender supply, look for manufacturers that already hold an approval in your market and can increase output.
- In a critical shortage, the FDA can allow temporary importation of a version approved in a well-regulated market. That decision is made by the FDA, case by case.
- Qualify any new source as carefully as at any other time: GMP certificate, registration status and a certificate of analysis for each batch.
More: where licensed suppliers can step in during US shortages.
Need Epinephrine Bitartrate, Lidocaine Hydrochloride Injection?
Send a request with your market, strength and quantity. We match licensed buyers with qualified suppliers.
Request a quote I can supply thisFollow this shortage
We email you when its status changes. Confirm first; unsubscribe any time.
Related shortages
For information only. Shortage status changes often; confirm with the regulator before making decisions. Brand names, where shown, are trademarks of their owners.
